par Arecco, Luca;Blondeaux, Eva;Bruzzone, Marco;Latocca, Maria Maddalena;Mariamidze, Elene;Begijanashvili, Salome;Sokolovic, Emir;Gentile, Giulia;Scavone, Graziana;Ottonello, Silvia;Boutros, Andrea;Vaz-Luis, Ines;Saura, Cristina;Anderson, R A;Demeestere, Isabelle ;Azim, H A;de Azambuja, Evandro ;Peccatori, Fedro Alessandro;Del Mastro, L;Partridge, Ann H;Lambertini, Matteo Md Phd M.
Référence ESMO Open, 8, 6, page (102031)
Publication Publié, 2023-12-01
Référence ESMO Open, 8, 6, page (102031)
Publication Publié, 2023-12-01
Article révisé par les pairs
Résumé : | Despite increasing evidence on the safety of pregnancy after anticancer treatments in breast cancer survivors, many physicians and patients remain concerned about a potential risk of pregnancy specifically in the case of hormone receptor-positive breast cancer. |